Using world models for AI drug discovery, Tongji professor raises tens of millions of yuan

What happened: PerturbMind AI, an AI for Science company founded by Tongji University researcher Chuo Guohui, announced it has raised tens of millions of yuan in angel and angel+ funding led by Qingsong Capital, with Tongyang Fund and several pharma companies participating. Why it matters: The company aims to shift AI drug discovery from target-centric screening to inferring how life systems change under intervention, and says it has signed a strategic pact with a leading domestic chip firm, with its PerturbSeek engine adapted to domestic GPUs.

PerturbMind AI, an AI for Science company founded by Tongji University researcher Chuo Guohui, announced it has raised tens of millions of yuan in angel and angel+ funding led by Qingsong Capital, with Tongyang Fund and several pharma companies participating.

The company aims to shift AI drug discovery from target-centric screening to inferring how life systems change under intervention, and says it has signed a strategic pact with a leading domestic chip firm, with its PerturbSeek engine adapted to domestic GPUs.